Table 2.
Adipose tissue content and function in patients with TG/HDL-C >3 and TG/HDL-C ≤3.
| TG/HDL-C ≤3 (n=17) | TG/HDL-C >3 (n=11) | p | |
|---|---|---|---|
| Sex (Female) | 16 (94%) | 8 (73%) | 0.1 |
| Age (y) | 44.0 (39.0–54.0) | 42.0 (38.0–54.0) | 0.6 |
| BMI (kg/m2) | 23.6 (22.0–27.5) | 26.5 (23.2–29.4) | 0.1 |
| FMI (kg/m2) | 7.7 (7.0–9.7) | 8.7 (8.1–9.7) | 0.5 |
| FFMI (kg/m2) | 16.3 (15.0–17.9) | 17.5 (16.9–20.9) | 0.1 |
| % of fat | 33.4 (31.9–35.0) | 33.1 (27.8–36.0) | 0.8 |
| Resistin (ng/ml) | 4.0 (3.5–6.6) | 6.6 (5.1–17.5) | 0.03 |
| Leptin (ng/ml) | 14.1 (8.5–26.9) | 17.6 (6.9–27.0) | 0.9 |
| Adiponectin (ng/ml) | 448.0 (360.0–519.0) | 334.0 (259.0–463.0) | 0.1 |
| Visfatin (ng/ml) | 61.1 (45.7–113.1) | 101.4 (23.0–136.9) | 1.0 |
Continuous variables are presented as median (interquartile range). BMI – body mass index; FFMI – fat-free mass index; FMI – fat mass index; TG/HDL-C – triglyceride-to-high-density lipoprotein cholesterol ratio.